by David Kent | Jun 24, 2016
The 2016 Annual Meeting of the International Society for Stem Cell Research got off to a fantastic start Wednesday night in San Francisco. Two excellent sessions were delivered to a packed house with talks ranging from the importance of circular RNAs (Pier Paolo...
by Paul Krzyzanowski | Apr 22, 2014
> If you’ve stayed current with the STAP cell fiasco you know it’s been a wild ride. STAP cells, or Stimulus-Triggered Acquisition of Pluripotency cells, caught the imagination of many in late January through their sheer simplicity: You hit cells with a shock of...
by Lisa Willemse | Jan 31, 2014
> By now, most readers will be familiar with this week’s announcement of a remarkable new discovery that mouse cells were made pluripotent using a relatively simple and quick acid bath technique. For those who aren’t, there’s reams of coverage,...
by Paul Krzyzanowski | Sep 10, 2013
. Earlier this summer I had the fortunate opportunity to speak with Dr. Michael West, of BioTime, and pick his brain on various aspects of the stem cell industry, what it’s faced, and where it might go. It was a perfect follow up to my post in March that explored...
by Paul Krzyzanowski | Nov 21, 2012
While the 2012 US election was in full swing, I reminded readers that despite the dominance of the world’s economic problems in this cycle, stem cell research was a political issue that hadn’t completely gone away.[pullquote]Ironically, if – and this is a...
Comments